Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility

Fang Wang,Shujia Huang,Rongsui Gao,Yuwen Zhou,Changxiang Lai,Zhichao Li,Wenjie Xian,Xiaobo Qian,Zhiyu Li,Yushan Huang,Qiyuan Tang,Panhong Liu,Ruikun Chen,Rong Liu,Xuan Li,Xin Tong,Xuan Zhou,Yong Bai,Gang Duan,Tao Zhang,Xun Xu,Jian Wang,Huanming Yang,Siyang Liu,Qing He,Xin Jin,Lei Liu

DOI: https://doi.org/10.1038/s41421-020-00231-4

IF: 38.079

2020-11-10

Cell Discovery

Abstract:Abstract The COVID-19 pandemic has accounted for millions of infections and hundreds of thousand deaths worldwide in a short-time period. The patients demonstrate a great diversity in clinical and laboratory manifestations and disease severity. Nonetheless, little is known about the host genetic contribution to the observed interindividual phenotypic variability. Here, we report the first host genetic study in the Chinese population by deeply sequencing and analyzing 332 COVID-19 patients categorized by varying levels of severity from the Shenzhen Third People’s Hospital. Upon a total of 22.2 million genetic variants, we conducted both single-variant and gene-based association tests among five severity groups including asymptomatic, mild, moderate, severe, and critical ill patients after the correction of potential confounding factors. Pedigree analysis suggested a potential monogenic effect of loss of function variants in GOLGA3 and DPP7 for critically ill and asymptomatic disease demonstration. Genome-wide association study suggests the most significant gene locus associated with severity were located in TMEM189–UBE2V1 that involved in the IL-1 signaling pathway. The p.Val197Met missense variant that affects the stability of the TMPRSS2 protein displays a decreasing allele frequency among the severe patients compared to the mild and the general population. We identified that the HLA-A*11:01, B*51:01, and C*14:02 alleles significantly predispose the worst outcome of the patients. This initial genomic study of Chinese patients provides genetic insights into the phenotypic difference among the COVID-19 patient groups and highlighted genes and variants that may help guide targeted efforts in containing the outbreak. Limitations and advantages of the study were also reviewed to guide future international efforts on elucidating the genetic architecture of host–pathogen interaction for COVID-19 and other infectious and complex diseases.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the contribution of host genetic factors to the severity and susceptibility of COVID - 19. Specifically, through in - depth analysis of the whole - genome sequencing data of 332 COVID - 19 patients admitted to the Third People's Hospital in Shenzhen, China, the researchers aimed to identify genetic variations related to disease progression. These patients were divided into five groups according to the criteria of the Chinese Center for Disease Control and Prevention: asymptomatic, mild, moderate, severe, and critical.

The main objectives of the study include:
1. **Identify genetic variations related to the severity of COVID - 19**: Through single - variant and gene - based genome - wide association studies (GWAS) of a large number of genetic variations, look for genetic loci that may affect the severity of the disease.
2. **Evaluate the differences in the distribution of rare loss - of - function variants among patients with different severities**: Through family - based analysis and population - based strategies, explore whether there are specific loss - of - function variants that cause some patients to be more or less severely ill.
3. **Explore the roles of specific genes and variants in the pathological mechanism of COVID - 19**: Pay particular attention to genes such as ACE2 and TMPRSS2 that are known to be closely related to the process of virus entry into cells, and how their variants affect the development of the disease.

The research results show that the host genetic background plays an important role in determining an individual's response to SARS - CoV - 2 infection, especially in terms of the severity of the disease. For example, the study found that specific HLA alleles such as HLA - A*11:01, B*51:01, and C*14:02 significantly increase the risk of patient deterioration. In addition, the TMEM189 - UBE2V1 locus located in the 20q13.13 region is significantly associated with disease severity, suggesting that these genes may affect the clinical manifestations of patients by participating in the IL - 1 signaling pathway.

In conclusion, this study provides important genetic insights into understanding how host genetic factors affect the clinical heterogeneity of COVID - 19, and provides a scientific basis for future precision medicine and epidemic prevention and control strategies.